USPTO serial 87765424
PRXL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARMON, RAYMOND E
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PRXL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
D. Peter Harvey
D. Peter Harvey HARVEY & COMPANYFOUR EMBARCADERO CENTER, 14TH FLOORSAN FRANCISCO, CA 94111-4164UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; market analysis; providing business and statistical information and data processing services in the pharmaceutical, biotechnology, medical device, and diagnostics industries | ACTIVE | — |
| 038 | Computer services, namely, provision of access to a computer network in connection with clinical trials and drug development | ACTIVE | — |
| 042 | Conducting clinical trials for others; research and development in the field of pharmaceuticals, biopharmaceuticals, medical devices, and medical diagnostics; clinical research in the field of production of chemicals, pharmaceuticals, medical devices and medical diagnostics; providing interactive web sites featuring technology that enables users to collect, review, analyze and report on clinical trial and drug development information; providing temporary use of online non-downloadable software to allow users to collect, review, analyze and report on clinical trials and drug development; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with clinical trials and drug development | ACTIVE | — |
| 045 | Advice and regulatory compliance consulting in the field of pharmaceuticals, biopharmaceuticals, medical devices, and diagnostics; regulatory compliance research in the field of approval, registration and production of chemicals, pharmaceuticals, medical devices, and diagnostics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PAREXEL International Corporation
- Other trademarks owned by PAREXEL International Corporation
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named PRXL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 12, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 11, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 9, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 5, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 5, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 5, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 10, 2021 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 10, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 8, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 8, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 8, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 6, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 4, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 4, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 4, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 6, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 4, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 4, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 5, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 9, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 9, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 9, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 9, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 9, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 9, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 9, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 2, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 25, 2018 | NWAP | NEW APPLICATION ENTERED | — |